Member Info for MR.Spacetomato

jdt1990,

Thank you for having the time to write this text and your views on the company. I sincerely appreciate it.

Indeed, the dilution kills the value for shareholders and I am sorry it has affected you. Mining as well as Oilers are risky shares even without dilution and I have my fair share of risk taking in both sectors, so if I invest here it would not be enough to break the bank.

I will wait a little more to see where the sp settles in the coming weeks. The prospect looks good though. I will read more about KDR and make a decision in the coming weeks.

Once again I am much obliged for your input and wish you good luck here and avct.

Take care

ST

O2, I think 3M is just the manufacturer...the real McCoy there is MIT.

Richob, not a word from him yet. Now, still trying to figure out what the problem is with Yorkshirep?

https://www.ft.com/content/18cd64a6-48d0-48fa-ba85-8c54373fcd0d

All it takes is to have a good platform and avacta has plenty.

Good morning, lads.

I have just come across KDR after reading the RNS. I used to invest in mining, if I can call that, almost 20 years ago, then moved to oil exploration companies and find myself in pharmas lately, so very rusty.

I will do my own research on KDR this week to get a feeling for it and refresh the little I knew about mining.

However, I would appreciate if some of the KDR veterans would say to a potential small investor thinking of jumping in? I would like to thank you in advance for any views put forward.

Thanks

ST

Agree, At-home. Madusa created confusion and annoyance.

Pigster, imagining that was the case and based on what prof Smith has achieved so far regarding negotiated JVs as far as retaining affimer technology, I would assume we would keep about 45% of the rights. So, another finger in another front.

Not to mention that the Yale test has accuracy from 88% to 94% ...not sure where their sensitivity stands.

Bams

The bans test is way better and we are about to get the results of trial soon. The Brits will rock and make Yale go pale.

If I remember rightly this test is not straight forward and needs equipment. Results available three hours after collecting and needs a technician.

"Additionally, the SalivaDirect methodology has been validated and authorized for use with different combinations of commonly used reagents and instruments, meaning the test could be used broadly in most high-complexity labs".

Spike66, great find. It seems that the scientific community is clearly starting to side with rapid antigen tests over the counter...they will be making these saliva test like sausages.

DOH, believe or not it crossed my mind. ;0)

VR, I agree with what you just said. I think whilst we all wait for the news, considering we all invested our money on avct, we will try to turn every stone on the way to see if there is anything we haven't probed yet. Tick-tock, tick-tock...

Have a good weekend all.

ST

vrmnd,

" it seems people on here can‘t even seem to get ancient (or recent RNS) references right. No surprise the good posters (and readers) are getting flushed out"...

What patronising statements, I would say. Anyone even with a mediocre education, or with google access would know or understand the reference to Medusa (and possibly how it's head looked like the virus and associated myths) let's be honest here.

Yes, in my opinion Medusa 19 is cheap and doesn't sound professional at all. I expected much better from any company associated with Avacta and prof Smith. Medusa 19 sounds cheap and a title I would expect coming from someone with little imagination and lacking finesse. I would never imagine the likes of AstraZeneca or Roche to pick something like unimaginative as that, despite trying to show they heard of medusa.

ST

In my view Medusa (even the name is not professional) will represent nothing to us as it is, in theory, set up to sell the tests to Tom, Dick and Harry.

In reality, the BBI and other future manufacturers Avacta says is negotiating with, that will handle the real orders; Governments and big businesses and organisations. That's where the real money will be.

Have a good night.

Cheers
ST

EnergyShares,

Can I ask you where you got this, apart the obvious "Twitter".

FDA cut off -
Sensitivity/+ve % agreement 90%
Specificity/-ve % agreement 95%
#COVID__19

I read the FDA and last time I checked sensitivity was 95% for LFAs antigen.

Thanks in advance

St

summers,

Was it Aj Bell platform? It happened to me with avacta, but managed to get back in cheaper. Good luck on monday.

Mr.Big, code 1? Blasphemy!

Price stable at 240. It would not surprise me if we had another quietly bought over £1ml shortly.

ST